Kratom Scientists Pen Letter Questioning Case Report Review
Dr. Cachat and Brian look at a letter (Smith et al, 2022) authored by former Kratom Science Podcast guests Dr. Kirsten Smith, Dr. Oliver Grundmann, Dr. Chris McCurdy, Dr. Darshan Singh, and other experts in the kratom field. The letter questions a systematic review (Broyan et al, 2022) of kratom case reports that offers buprenorphine as a solution to “kratom use disorder”. Kratom-related case reports typically originate with patients showing up to emergency rooms and physicians’ offices with symptoms. In these case reports, kratom product samples are rarely if ever tested for adulterants or contamination. The strength of the kratom product and dose levels seem to nearly always go unreported or wildly misreported (for example, the Broyan et al. review the Smith et al. letter addresses here claims the patients consumed an average of 92 grams of kratom per day). Furthermore, history or current use of other drugs is often overlooked.
Dr. Jon also talks about his trouble getting public data on cannabis testing and use trends from the State of Ohio’s Marijuana Enforcement Tracking Reporting & Compliance (METRC) program.
References
Broyan, V. R., Brar, J. K., Allgaier Student, T., & Allgaier, J. T. (2022). Long-term buprenorphine treatment for kratom use disorder: A case series. Substance abuse, 43(1), 763–766. https://doi.org/10.1080/08897077.2021.2010250Smith, K. E., Dunn, K. E., Epstein, D. H., Feldman, J. D., Garcia-Romeu, A., Grundmann, O., Henningfield, J. E., McCurdy, C. R., Rogers, J. M., Schriefer, D., Singh, D., & Weiss, S. T. (2022). Need for clarity and context in case reports on kratom use, assessment, and intervention. Substance abuse, 43(1), 1221–1224. https://doi.org/10.1080/08897077.2022.2074608https://www.metrc.com/0
Sign in to leave a comment.